These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Phase II study of combined vincristine, adriamycin, cyclophosphamide, and methotrexate with citrovorum factor factor rescue in metastatic breast cancer. Mattsson W, Arwidi A, von Eyben F, Lindholm CE. Cancer Treat Rep; 1977 Nov; 61(8):1527-31. PubMed ID: 303543 [Abstract] [Full Text] [Related]
9. Combination chemotherapy for disseminated carcinoma of the breast. Lozada JA, Grillo-López A, Vélez-Garciá E. Bol Asoc Med P R; 1975 Jun; 67(6):157-63. PubMed ID: 1055588 [No Abstract] [Full Text] [Related]
12. A randomized comparative trial of adriamycin versus methotrexate in combination drug therapy. Bull JM, Tormey DC, Li SH, Carbone PP, Falkson G, Blom J, Perlin E, Simon R. Cancer; 1978 May; 41(5):1649-57. PubMed ID: 348293 [Abstract] [Full Text] [Related]
13. Multicentre combined chemotherapy protocol for large cell advanced non Hodgkin's lymphoma. Dumont J, Charpy-Validire P, Mosseri V, Gabarre J, Belanger C, Turpin F, Binet JL, Dreyfus F, Fourquet A, Janvier M. Hematol Oncol; 1991 May; 9(4-5):197-207. PubMed ID: 1720759 [Abstract] [Full Text] [Related]
14. Combination chemotherapy in advanced postmenopausal mammary carcinoma. A comparison between VAC and VACM therapy. Mattsson W, Arwidi A, von Eyben F, Lindholm CE. Acta Radiol Oncol Radiat Phys Biol; 1979 May; 18(5):431-44. PubMed ID: 394576 [Abstract] [Full Text] [Related]
15. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)]. Michlmayr G, Kratzer H, Denz H, Huber H. Wien Klin Wochenschr; 1981 Mar 20; 93(6):205-7. PubMed ID: 7281697 [Abstract] [Full Text] [Related]
16. [Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy]. Mouridsen HT, Palshof T, Brahm M, Rahbek I. Ugeskr Laeger; 1977 Oct 31; 139(44):2632-5. PubMed ID: 929742 [No Abstract] [Full Text] [Related]
17. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone. Frederiksen PL, Joergensen ST, Roesdahl K, Thomsen J, Mouridsen HT. Cancer Treat Rep; 1978 Mar 31; 62(3):449-50. PubMed ID: 348314 [No Abstract] [Full Text] [Related]
20. A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer: a Southeastern Cancer Study Group project. Smalley RV, Carpenter J, Bartolucci A, Vogel C, Krauss S. Cancer; 1977 Aug 31; 40(2):625-32. PubMed ID: 329975 [Abstract] [Full Text] [Related] Page: [Next] [New Search]